Pearson Medical Technologies Launches New Software for Pharmacy DSCSA Compliance
TL;DR
Pearson Medical Technologies introduces M-Print bar code labeling software v4 for pharmacy drug supply chain security act (DSCSA) compliance, giving pharmacies a competitive advantage in meeting regulatory requirements.
The M-Print bar code labeling software v4 works by providing pharmacies with a comprehensive solution for labeling drugs and ensuring compliance with the DSCSA.
The introduction of M-Print bar code labeling software v4 makes the world a better place by enhancing the security and authenticity of pharmaceutical products, ultimately benefiting patients and healthcare providers.
Pharmacies can now streamline their drug labeling process and improve compliance with the DSCSA through Pearson Medical Technologies' innovative M-Print bar code labeling software v4.
Found this article helpful?
Share it with your network and spread the knowledge!
Pearson Medical Technologies has unveiled its latest software solution, m:Print Bar Code Labeling Software v4, aimed at assisting pharmacies in meeting the requirements of the Drug Supply Chain Security Act (DSCSA). This new version represents a significant advancement in pharmaceutical supply chain management and security.
The DSCSA, enacted to enhance drug traceability and reduce counterfeit medications, mandates that pharmacies implement systems to verify and track prescription drugs throughout the supply chain. Pearson's m:Print v4 directly addresses these regulatory demands by incorporating features that enable pharmacies to generate compliant bar code labels for prescription medications.
Key features of the m:Print v4 software include the ability to create 2D data matrix barcodes containing essential product information such as National Drug Code (NDC), serial number, lot number, and expiration date. This functionality is crucial for pharmacies to maintain accurate records and ensure the authenticity of medications dispensed to patients.
The introduction of this software is particularly timely as the pharmaceutical industry approaches the DSCSA's full implementation deadline. Pharmacies that fail to comply with these regulations risk facing significant penalties and potential disruptions to their operations. By adopting m:Print v4, pharmacies can streamline their compliance efforts and potentially avoid costly regulatory issues.
Beyond regulatory compliance, the new software also offers benefits in terms of operational efficiency and patient safety. Improved tracking and verification capabilities can help reduce medication errors and enhance recall management, ultimately contributing to better patient outcomes and increased trust in the pharmaceutical supply chain.
As the healthcare industry continues to grapple with the challenges of drug security and traceability, solutions like Pearson's m:Print v4 play a crucial role in modernizing pharmacy operations and protecting public health. The software's release underscores the growing importance of technology in meeting complex regulatory requirements and maintaining the integrity of the pharmaceutical supply chain.
Curated from NewMediaWire
